This publication is provided for historical reference only and the information may be out of date.
- 3MS
Modified Mini-Mental State Examination
- AA
Arachidonic acid
- AACD
Aging-associated cognitive decline
- AAMI
Age-associated memory impairment
- ABI
Ankle-brachial index
- ACE
Angiotensin 1 converting enzyme
- ACTIVE
Advanced Cognitive Training for Independent and Vital Elderly trial
- AD
Alzheimer’s disease
- ADAPT
Alzheimer’s Disease Anti-inflammatory Prevention Trial
- ADAS-Cog
Alzheimer Disease Assessment Scale-Cognitive subscale
- ADEPT
Adult Development and Enrichment Project;
- ADL(s)
Activities of daily living
- AHRQ
Agency for Healthcare Research and Quality
- aMCI
Amnestic mild cognitive impairment
- ApoE
Apolipoprotein E protein
- APOE
Apolipoprotein E gene
- APOE e4
Epsilon 4 allele of the apolipoprotein E gene
- APP
Amyloid precursor protein
- ARIC
Atherosclerosis Risk in Communities study
- ASA
Acetylsalicylate (aspirin)
- AVLT
Auditory Verbal Learning Test
- BDI
Beck Depression Inventory
- BMI
Body mass index
- BNT
Boston Naming Test
- BP
Blood pressure
- BSRT
Babcock Story Recall Test
- BVRT
Benton Visual Retention Test
- CAD
Coronary artery disease
- CASI
Cognitive Abilities Screening Instrument
- CDR
Clinical Dementia Rating
- CDR-SB
Clinical Dementia Rating-sum of boxes
- CEE
Conjugated equine estrogen
- CERAD
Consortium to Establish a Registry for Alzheimer’s Disease
- CES-D
Center for Epidemiologic Studies Depression scale
- CHD
Coronary heart disease
- CHF
Congestive heart failure
- CI
Confidence interval
- CIND
Cognitive impairment not demented
- CNS
Central nervous system
- COPD
Chronic obstructive pulmonary disease
- COWA
Controlled Oral Word Association test
- CRP
C-reactive protein
- CSI-D
Community Screening Interview for Dementia
- CVA
Cerebrovascular accident
- CVD
Cardiovascular disease
- CVLT
California Verbal Learning Test
- DBP
Diastolic blood pressure
- DCT
Digit Cancellation Test
- DHA
Docosahexaenoic acid
- DHEA
Dehydroepiandosterone
- DHP-CCB
Dihydropyridine-calcium channel blockers;
- DM
Diabetes mellitus
- DSM
Diagnostic and Statistical Manual of Mental Disorders
- DSST
Digit Symbol Substitution Test
- DWR
Delayed word recall
- EPA
Eicosapentaenoic acid
- EPC
Evidence-based Practice Center
- FTT
Finger Tapping Test
- GDS
Geriatric Depression Scale
- GEE
Generalized estimated equations
- GRADE
Grading of Recommendations Assessment, Development and Evaluation
- GWAS
Genome-wide association studies
- HDL
High density lipoprotein
- HDL-C
High density lipoprotein cholesterol
- HDRS
Hamilton Depression Rating Scale
- HDDS
Hasegawa Dementia Screening Scale
- HFFQ
Harvard Food Frequency Questionnaire
- HMG-CoA
3-hydroxy-3-methylglutaryl-coenzyme A
- HMO
Health maintenance organization
- HR
Hazard ratio
- HRT
Hormone replacement therapy
- HTN
Hypertension
- IADL
Instrumental activities of daily living
- IL-1B
Interleukin-1beta
- IL-6
Interleukin-6
- IQ
Intelligence quotient
- JNC VII
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
- LDL
Low density lipoprotein
- MAC
Memory assessment clinics
- MCD
Mild cognitive disorder
- MCI
Mild cognitive impairment
- MDD
Major depressive disorder
- MeSH
Medical Subject Heading
- MI
Myocardial infarction
- MMSE
Mini-Mental State Examination
- MNC
Mild neurocognitive disorder
- MPA
Medroxyprogesterone acetate
- mTICS
modified Telephone interview for cognitive status
- MUFA(s)
Monounsaturated fatty acid
- NCEP-ATPIII
National Cholesterol Education Program 3rd Adult Treatment Panel Guideline
- NIH
National Institutes of Health
- NIMH
National Institutes of Mental Health
- NINCDS-ADRDA
National Institute of Neurological and Communicative Diseases and Stroke-Alzheimer’s Disease and Related Disorders Association
- NS
Not statistically significant
- NSAID(s)
Non-steroidal anti-inflammatory drug(s)
- NYU
New York University
- OMAR
Office of Medical Applications of Research
- OR
Odds ratio
- PMA
Primary Mental Abilities
- PUFA(s)
Polyunsaturated fatty acid(s)
- PVD
Peripheral vascular disease
- RCT
Randomized controlled trial
- RERI
Relative excess risk from interaction
- RR
Relative risk
- RVLT
Rey Auditory Verbal Learning Test
- SBP
Systolic blood pressure
- SCOPE
Study on Cognition and Prognosis in the Elderly
- SD
Standard deviation
- SDMT
Symbol Digit Modalities Test
- SE
Standard error
- SERM
Selective estrogen receptor modulator
- SES
Socioeconomic status
- SF-36
Medical Outcomes Study 36-Item Short Form Health Survey
- SFA(s)
Saturated fatty acid(s)
- SHEP
Systolic Hypertension in the Elderly Program
- SNP
Single-nucleotide polymorphism
- SPMSQ
Short Portable Mental Status Questionnaire
- STAI
State Trait Anxiety Inventory
- Syst-Eur
Systolic Hypertension in Europe trial
- TBI
Traumatic brain injury
- TEP
Technical expert panel
- TFAM
Transcription factor A, mitochondrial
- TIA
Transient ischemic attack
- TICS
Telephone Interview for Cognitive Status
- TICS-m
Telephone Interview for Cognitive Status (modified version)
- TNK1
Tyrosine kinase, non-receptor 1
- Trails A/B
Trail Making Test Part A/B
- Trails B
Trail Making Test Part B
- VA
United States Department of Veterans Affairs
- VAD
Vascular Alzheimer’s disease
- VRT
Visual Reproduction Test (immediate and delayed recall) from the Wechsler Memory Scale
- WAIS
Wechsler Adult Intelligence Scale
- WAIS-R
Wechsler Adult Intelligence Scale-Revised
- WF
Word Fluency Test
- WMD
Weighted mean difference
- WMS
Wechsler Memory Scale
- WMS-R
Wechsler Memory Scale-Revised
Publication Details
Copyright
Publisher
Agency for Healthcare Research and Quality (US), Rockville (MD)
NLM Citation
Williams JW, Plassman BL, Burke J, et al. Preventing Alzheimer's Disease and Cognitive Decline. Rockville (MD): Agency for Healthcare Research and Quality (US); 2010 Apr. (Evidence Reports/Technology Assessments, No. 193.) Acronyms and Abbreviations.